President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships · Schrodinger, Inc. (SDGR)

Karen Akinsanya

A named executive officer of Schrodinger in every fiscal year CompBrief holds from FY2019 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$2,110,924

FY2024: $2,736,718

2nd of 6 named executive officers at Schrodinger by FY2025 total.

6 named officers on file for Schrodinger, FY2025

See an example →

What this number hides

The filing gives the total. Schrodinger’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how Schrodinger’s whole pay program stands against its peers

  • Schrodinger’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SDGR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-10.

Free

Get Karen Akinsanya’s full pay file as a PDF — free

More than this page: up to 10 years of Karen’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Karen Akinsanya and every company like it: Velarion Intel, free for 3 days, no card →

Karen Akinsanya compensation by year

Schrodinger Summary Compensation Table · all 7 fiscal years held
In US dollars, as Schrodinger reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Salary$330,000$400,000$460,000$515,375$541,000$562,640$600,000
Bonus$0$0$0$0$0$0$0
Stock awards$0$0$0$0$0$0$331,875
Option awards$0$1,679,025$3,984,414$1,070,644$882,663$1,805,307$834,824
Non-equity incentive$99,000$240,000$193,200$249,600$243,450$355,870$331,200
Pension and deferred compensation$0$0$0$0$0$0$0
All other$11,701$11,901$12,101$12,701$13,287$12,901$13,025
Total$440,701$2,330,926$4,649,715$1,848,320$1,680,400$2,736,718$2,110,924

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Schrodinger, Inc. DEF 14A filed April 28, 2026, accession 0001490978-26-000026, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Schrodinger, Inc. filed document, accession 0001490978-26-000026. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

$441K
$2.3M
$4.6M
$1.8M
$1.7M
$2.7M
$2.1M
FY19
FY20
FY21
FY22
FY23
FY24
FY25
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU27,576$493,059—
RSU15,625$279,375—
PSU7,813$139,696—
Option18,454—$23.29
Option3,334—$27.76
Option67,500—$25.24
Option62,500—$21.24

Per the Outstanding Equity Awards at Fiscal Year-End table in Schrodinger, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

4 Form 4 lines since the FY2025 proxy (filed April 28, 2026)
current to 2026-11-10 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-09-17Exercise or conversion10b5-131,599$4.34101,555
2026-09-17Sale10b5-110,000$28.0091,555
2026-09-17Sale10b5-121,599$30.0069,956
2026-09-17Exercise or conversion derivative10b5-131,599$0.0011,599

The 4 most recent of 4 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments Schrodinger discloses, by trigger · FY2025
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Resignation for good reason, no change in control$0$0$0$0
Change in control and involuntary termination$600,000$279,375$40,496$1,279,871
Change in control, no termination$0$0$0$0
Involuntary termination without cause$450,000$0$40,496$490,496

Per the Potential Payments Upon Termination or Change in Control table in Schrodinger, Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.

Schrodinger’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Ramy FaridPresident and Chief Executive Officer$4,079,043
Karen Akinsanya · this pagePresident, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships$2,110,924
Geoffrey PorgesFormer Executive Vice President, Chief Financial Officer$2,021,911
Mannix AklianExecutive Vice President, Chief Commercial Officer, Global Head of Software Sales and Marketing$2,011,376
Yvonne TranExecutive Vice President, Chief Legal Officer and Chief People Officer$1,800,806
Richie JainExecutive Vice President, Chief Financial Officer$1,795,930

Karen Akinsanya's compensation dossier, Schrodinger

You have read Karen Akinsanya's totals and holdings. The dossier adds each equity grant Schrodinger disclosed for Karen Akinsanya and Schrodinger's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full Schrodinger compensation record

free company brief

This page is one person within Schrodinger's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Schrodinger proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Schrodinger's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Schrodinger's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order SDGR

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Karen Akinsanya's compensation dossier